BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26522614)

  • 1. BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages.
    Rosati A; Basile A; D'Auria R; d'Avenia M; De Marco M; Falco A; Festa M; Guerriero L; Iorio V; Parente R; Pascale M; Marzullo L; Franco R; Arra C; Barbieri A; Rea D; Menichini G; Hahne M; Bijlsma M; Barcaroli D; Sala G; di Mola FF; di Sebastiano P; Todoric J; Antonucci L; Corvest V; Jawhari A; Firpo MA; Tuveson DA; Capunzo M; Karin M; De Laurenzi V; Turco MC
    Nat Commun; 2015 Nov; 6():8695. PubMed ID: 26522614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAG3-positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma.
    Yuan Y; Jiang JY; Wang JM; Sun J; Li C; Liu BQ; Yan J; Meng XN; Wang HQ
    J Cell Mol Med; 2019 Aug; 23(8):5006-5016. PubMed ID: 31119886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of BAG3 in cancer progression: A therapeutic opportunity.
    De Marco M; Basile A; Iorio V; Festa M; Falco A; Ranieri B; Pascale M; Sala G; Remondelli P; Capunzo M; Firpo MA; Pezzilli R; Marzullo L; Cavallo P; De Laurenzi V; Turco MC; Rosati A
    Semin Cell Dev Biol; 2018 Jun; 78():85-92. PubMed ID: 28864347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration.
    Dufrusine B; Damiani V; Capone E; Pieragostino D; Dainese E; De Marco M; Reppucci F; Turco MC; Rosati A; Marzullo L; Sala G; Sallese M; De Laurenzi V
    J Cell Biochem; 2022 Jan; 123(1):65-76. PubMed ID: 34741485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAG3 deletion suppresses stem cell-like features of pancreatic ductal adenocarcinoma via translational suppression of ISG15.
    Li XY; Yan J; Sun J; Li C; Jiang JY; Wang JM; Meng XN; Liang JJ; Wang HQ
    Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):819-827. PubMed ID: 30771383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer.
    Basile A; De Marco M; Festa M; Falco A; Iorio V; Guerriero L; Eletto D; Rea D; Arra C; Lamolinara A; Ballerini P; Damiani V; Rosati A; Sala G; Turco MC; Marzullo L; De Laurenzi V
    Mol Oncol; 2019 Jun; 13(6):1388-1399. PubMed ID: 30973679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAG3 directly stabilizes Hexokinase 2 mRNA and promotes aerobic glycolysis in pancreatic cancer cells.
    An MX; Li S; Yao HB; Li C; Wang JM; Sun J; Li XY; Meng XN; Wang HQ
    J Cell Biol; 2017 Dec; 216(12):4091-4105. PubMed ID: 29114069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAG3 regulates stability of IL-8 mRNA via interplay between HuR and miR-4312 in PDACs.
    Li C; Jiang JY; Wang JM; Sun J; An MX; Li S; Yan J; Wang HQ
    Cell Death Dis; 2018 Aug; 9(9):863. PubMed ID: 30154469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAG3 induces α-SMA expression in human fibroblasts and its over-expression correlates with poorer survival in fibrotic cancer patients.
    De Marco M; Del Papa N; Reppucci F; Iorio V; Basile A; Falco A; Iaccarino R; Brongo S; De Caro F; Capunzo M; Turco MC; Rosati A; Marzullo L
    J Cell Biochem; 2022 Jan; 123(1):91-101. PubMed ID: 34741483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer: New insights into PDAC growth promotion via a BAG3-mediated paracrine loop.
    Ray K
    Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):669. PubMed ID: 26577348
    [No Abstract]   [Full Text] [Related]  

  • 11. LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.
    Zhao T; Ren H; Li J; Chen J; Zhang H; Xin W; Sun Y; Sun L; Yang Y; Sun J; Wang X; Gao S; Huang C; Zhang H; Yang S; Hao J
    Cancer Res; 2015 Jan; 75(1):111-9. PubMed ID: 25385028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
    Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
    Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lutein induces an inhibitory effect on the malignant progression of pancreatic adenocarcinoma by targeting BAG3/cholesterol homeostasis.
    Han L; Song X
    J Biochem Mol Toxicol; 2022 Feb; 36(2):e22958. PubMed ID: 34783111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma.
    Teodorczyk M; Kleber S; Wollny D; Sefrin JP; Aykut B; Mateos A; Herhaus P; Sancho-Martinez I; Hill O; Gieffers C; Sykora J; Weichert W; Eisen C; Trumpp A; Sprick MR; Bergmann F; Welsch T; Martin-Villalba A
    Cell Death Differ; 2015 Jul; 22(7):1192-202. PubMed ID: 25613377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of PUMA in pancreatic ductal adenocarcinoma.
    Du QH; Zhang KJ; Jiao XL; Zhao J; Zhang M; Yan BM; Xu YB
    J Int Med Res; 2012; 40(6):2066-72. PubMed ID: 23321162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
    Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
    J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease.
    Kirk JA; Cheung JY; Feldman AM
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34396980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
    Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
    Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.